ConvaTec Group PLC reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 2,289.2 million compared to USD 2,142.4 million a year ago. Net income was USD 190.5 million compared to USD 130.3 million a year ago. Basic earnings per share from continuing operations was USD 0.093 compared to USD 0.064 a year ago. Diluted earnings per share from continuing operations was USD 0.093 compared to USD 0.063 a year ago. ConvaTec Group PLC reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 2,289.2 million compared to USD 2,142.4 million a year ago. Net income was USD 190.5 million compared to USD 130.3 million a year ago. Basic earnings per share from continuing operations was USD 0.093 compared to USD 0.064 a year ago. Diluted earnings per share from continuing operations was USD 0.093 compared to USD 0.063 a year ago.
ConvaTec is an England based medical device company that develops and commercializes critical care and infusion devices for the treatment of chronic conditions.